Concord Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22

Sales

457.17

339.90

Operating profit

191.34

102.55

Interest

1.59

2.15

Gross profit

204.53

114.26

EPS (Rs)

12.71

6.27

Other income

14.78

13.86

Stock adjustment

-10.28

-17.93

Raw material

81.48

80.37

Power and fuel

-

-

Employee expenses

58.42

54.05

Excise

-

-

Admin and selling expenses

-

-

Research and development expenses

-

-

Expenses capitalised

-

-

Other expenses

136.22

120.87

Provisions made

-

-

Depreciation

26.34

26.08

Taxation

45.23

22.64

Net profit / loss

132.96

65.55

Extra ordinary item

-

-

Prior year adjustments

-

-

Equity capital

10.46

10.46

Equity dividend rate

-

-

Agg.of non-prom. shares (Lacs)

-

-

Agg.of non promotoholding (%)

-

-

OPM (%)

41.85

30.17

GPM (%)

43.34

32.30

NPM (%)

28.17

18.53